|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1701 to 1800 out of 1828 for Rb1

0.051s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
Publication
First Author: Simin K
Year: 2004
Journal: PLoS Biol
Title: pRb inactivation in mammary cells reveals common mechanisms for tumor initiation and progression in divergent epithelia.
Volume: 2
Issue: 2
Pages: E22
•
•
•
•
•
Allele
Name: transgene insertion 1, Brenda L Gallie
Allele Type: Transgenic
Attribute String: Inserted expressed sequence
•
•
•
•
•
Genotype
Symbol: Calca/Calca<+> Trp53/Trp53 Rb1/Rb1 Pten/Pten
Background: involves: 129 * 129P2/OlaHsd * 129S4/SvJae * BALB/c * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Symbol: Nell1/Nell1 Rb1/Rb1 Trp53/Trp53 Tg(BGLAP-cre)1Clem/?
Background: involves: 129 * FVB/NJ
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Symbol: Rb1/Rb1 Trp53/Trp53 Tg(BGLAP-cre)1Clem/?
Background: involves: 129 * 129P2/OlaHsd * FVB/NJ
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Rb1/Rb1 Tg(Prdm1-cre)1Masu/?
Background: involves: C57BL/6J
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Symbol: Rb1/Rb1 Rbl1/Rbl1 Trp53/Trp53 Tg(Chx10-EGFP/cre,-ALPP)2Clc/?
Background: involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * SJL
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Symbol: Rb1/Rb1 Rbl1/Rbl1<+> Trp53/Trp53 Tg(Chx10-EGFP/cre,-ALPP)2Clc/?
Background: involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * SJL
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Symbol: Rb1/Rb1 Rbl1/Rbl1<+> Tg(Chx10-EGFP/cre,-ALPP)2Clc/?
Background: involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * SJL
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Symbol: Rb1/Rb1 Rbl1/Rbl1 Trp53/Trp53 Tg(Chx10-EGFP/cre,-ALPP)2Clc/?
Background: involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * SJL
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Pten/Pten Rb1/Rb1 Tg(Pbsn-cre)4Prb/?
Background: involves: 129 * 129S1/Sv * 129S6/SvEvTac * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Pten/Pten Rb1/Rb1<+> Tg(Pbsn-cre)4Prb/?
Background: involves: 129 * 129S1/Sv * 129S6/SvEvTac * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Symbol: Pten/Pten Rb1/Rb1 Tg(Pbsn-cre)4Prb/?
Background: involves: 129 * 129S1/Sv * 129S6/SvEvTac * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Publication
First Author: S?nchez ER
Year: 1986
Journal: J Hered
Title: Wild-derived Robertsonian translocation in mice. Chromosome 17, Rb (16:17)7, shows novel interactions with t-alleles.
Volume: 77
Issue: 5
Pages: 290-4
•
•
•
•
•
Publication
First Author: Safronova LD
Year: 1993
Journal: Genetika
Title: [Disturbance of the relationship of transmission in male mice carrying the translocation Rb(8,17)1 Iem in combination with t-haplotypes].
Volume: 29
Issue: 12
Pages: 1992-9
•
•
•
•
•
Publication
First Author: Chen D
Year: 2002
Journal: Cancer Res
Title: Genomic amplification in retinoblastoma narrowed to 0.6 megabase on chromosome 6p containing a kinesin-like gene, RBKIN.
Volume: 62
Issue: 4
Pages: 967-71
•
•
•
•
•
Publication
First Author: Wang Y
Year: 2009
Journal: Cancer Prev Res (Phila)
Title: Preventive effects of bexarotene and budesonide in a genetically engineered mouse model of small cell lung cancer.
Volume: 2
Issue: 12
Pages: 1059-64
•
•
•
•
•
Allele
Name: transgene insertion 14, Sonia M Rocha-Sanchez
Allele Type: Transgenic
Attribute String: Dominant negative, Epitope tag, Humanized sequence, Inserted expressed sequence
•
•
•
•
•
Strain
Attribute String: coisogenic, mutant strain, targeted mutation
•
•
•
•
•
Publication
First Author: Romero R
Year: 2024
Journal: Nat Cancer
Title: The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1.
Volume: 5
Issue: 11
Pages: 1641-1659
•
•
•
•
•
Publication
First Author: Arora M
Year: 2023
Journal: Cell
Title: Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity.
Volume: 186
Issue: 12
Pages: 2628-2643.e21
•
•
•
•
•
Publication
First Author: Annunziato S
Year: 2019
Journal: Nat Commun
Title: Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer.
Volume: 10
Issue: 1
Pages: 397
•
•
•
•
•
Publication
First Author: Gong Y
Year: 2023
Journal: Dev Cell
Title: Loss of RanGAP1 drives chromosome instability and rapid tumorigenesis of osteosarcoma.
Volume: 58
Issue: 3
Pages: 192-210.e11
•
•
•
•
•
Publication
First Author: Lee S
Year: 2024
Journal: Cell Rep
Title: Loss of LPAR6 and CAB39L dysregulates the basal-to-luminal urothelial differentiation program, contributing to bladder carcinogenesis.
Volume: 43
Issue: 5
Pages: 114146
•
•
•
•
•
Publication
First Author: Fang L
Year: 2022
Journal: Cancer Gene Ther
Title: TMPRSS2-ERG promotes the initiation of prostate cancer by suppressing oncogene-induced senescence.
Volume: 29
Issue: 10
Pages: 1463-1476
•
•
•
•
•
Publication
First Author: Zhang Y
Year: 2026
Journal: Cell Death Differ
Title: Deprivation of EGFR signal causes senolysis in PDAC with CDK4/6 inhibition.
Volume: 33
Issue: 6
Pages: 1218-1233
•
•
•
•
•
Publication  
First Author: Wang ME
Year: 2023
Journal: J Clin Invest
Title: RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F/ACSL4 axis.
Volume: 133
Issue: 10
•
•
•
•
•
Publication
First Author: Chow RD
Year: 2017
Journal: Nat Neurosci
Title: AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma.
Volume: 20
Issue: 10
Pages: 1329-1341
•
•
•
•
•
Publication  
First Author: Hopkins J
Year: 2022
Journal: Cancers (Basel)
Title: PRELP Regulates Cell-Cell Adhesion and EMT and Inhibits Retinoblastoma Progression.
Volume: 14
Issue: 19
•
•
•
•
•
Publication
First Author: Brunelli JP
Year: 1999
Journal: Gene
Title: Sequence, expression and genetic mapping of a rainbow trout retinoblastoma cDNA.
Volume: 226
Issue: 2
Pages: 175-80
•
•
•
•
•
Publication
First Author: Bremner R
Year: 2010
Journal: Cancer Res
Title: Cyclins, Cdks, E2f, Skp2, and more at the first international RB Tumor Suppressor Meeting.
Volume: 70
Issue: 15
Pages: 6114-8
•
•
•
•
•
Publication
First Author: Peifer M
Year: 2012
Journal: Nat Genet
Title: Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer.
Volume: 44
Issue: 10
Pages: 1104-10
•
•
•
•
•
Publication
First Author: Holmfeldt L
Year: 2013
Journal: Nat Genet
Title: The genomic landscape of hypodiploid acute lymphoblastic leukemia.
Volume: 45
Issue: 3
Pages: 242-52
•
•
•
•
•
Publication
First Author: Hinds PW
Year: 2014
Journal: Cancer Discov
Title: A little pRB can lead to big problems.
Volume: 4
Issue: 7
Pages: 764-5
•
•
•
•
•
Publication
First Author: Zhu L
Year: 2015
Journal: Oncogene
Title: Antitumor mechanisms when pRb and p53 are genetically inactivated.
Volume: 34
Issue: 35
Pages: 4547-57
•
•
•
•
•
Publication
First Author: Akamatsu S
Year: 2015
Journal: Cell Rep
Title: The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer.
Volume: 12
Issue: 6
Pages: 922-36
•
•
•
•
•
Publication    
First Author: Papale A
Year: 2016
Journal: Elife
Title: Impairment of cocaine-mediated behaviours in mice by clinically relevant Ras-ERK inhibitors.
Volume: 5
•
•
•
•
•
Publication  
First Author: Giaccone G
Year: 2023
Journal: Semin Cancer Biol
Title: Current knowledge of small cell lung cancer transformation from non-small cell lung cancer.
Volume: 94
Pages: 1-10
•
•
•
•
•
Publication
First Author: Jin Y
Year: 2022
Journal: Natl Sci Rev
Title: Identification of TAZ as the essential molecular switch in orchestrating SCLC phenotypic transition and metastasis.
Volume: 9
Issue: 7
Pages: nwab232
•
•
•
•
•
Strain
Attribute String: transgenic, mutant stock
•
•
•
•
•
Publication
First Author: Huang J
Year: 2006
Journal: Nature
Title: Repression of p53 activity by Smyd2-mediated methylation.
Volume: 444
Issue: 7119
Pages: 629-32
•
•
•
•
•
Publication
First Author: Donlin LT
Year: 2012
Journal: Genes Dev
Title: Smyd2 controls cytoplasmic lysine methylation of Hsp90 and myofilament organization.
Volume: 26
Issue: 2
Pages: 114-9
•
•
•
•
•
Publication  
First Author: Ohtomo-Oda R
Year: 2016
Journal: Hum Pathol
Title: SMYD2 overexpression is associated with tumor cell proliferation and a worse outcome in human papillomavirus-unrelated nonmultiple head and neck carcinomas.
Volume: 49
Pages: 145-55
•
•
•
•
•
Publication
First Author: Bagislar S
Year: 2016
Journal: Oncotarget
Title: Smyd2 is a Myc-regulated gene critical for MLL-AF9 induced leukemogenesis.
Volume: 7
Issue: 41
Pages: 66398-66415
•
•
•
•
•
Protein Domain
Type: Domain
Description: This entry represents the SET domain of SET and MYND domain-containing protein 2 (SMYD2). SMYD2 functions as a histone methyltransferase that methylates both histones and non-histone proteins, including p53/TP53 and RB1 [, ]. It specifically methylates histone H3 'Lys-4' (H3K4me) and dimethylates histone H3 'Lys-36' (H3K36me2). It plays a role in myofilament organisation in both skeletal and cardiac muscles via Hsp90 methylation []. SMYD2 overexpression is associated with tumour cell proliferation and a worse outcome in human papillomavirus-unrelated nonmultiple head and neck carcinomas []. It regulates leukemia cell growth such that diminished SMYD2 expression upregulates SET7/9, thereby possibly shifting leukemia cells from growth to quiescence state associated with resistance to DNA damage associated with Acute Myeloid Leukemia (AML) [].The SMYD family consists of five members including SMYD1/2/3/4/5. They contain two highly conserved structural and functional domains, the SET and MYND domains. The SET domain is involved in lysine methylation, while the MYND domain is involved in protein-protein interaction. They are essential in several mammalian developmental pathways [, , , ].
•
•
•
•
•
Publication
First Author: Saddic LA
Year: 2010
Journal: J Biol Chem
Title: Methylation of the retinoblastoma tumor suppressor by SMYD2.
Volume: 285
Issue: 48
Pages: 37733-40
•
•
•
•
•
Publication
First Author: Hollern DP
Year: 2019
Journal: Breast Cancer Res Treat
Title: A mouse model featuring tissue-specific deletion of p53 and Brca1 gives rise to mammary tumors with genomic and transcriptomic similarities to human basal-like breast cancer.
Volume: 174
Issue: 1
Pages: 143-155
•
•
•
•
•
Publication
First Author: Kent LN
Year: 2017
Journal: J Clin Invest
Title: Dosage-dependent copy number gains in E2f1 and E2f3 drive hepatocellular carcinoma.
Volume: 127
Issue: 3
Pages: 830-842
•
•
•
•
•
Publication
First Author: Akeno N
Year: 2017
Journal: Mol Cancer Ther
Title: TRP53 Mutants Drive Neuroendocrine Lung Cancer Through Loss-of-Function Mechanisms with Gain-of-Function Effects on Chemotherapy Response.
Volume: 16
Issue: 12
Pages: 2913-2926
•
•
•
•
•
Publication
First Author: Yamamoto K
Year: 2015
Journal: Leukemia
Title: Early B-cell-specific inactivation of ATM synergizes with ectopic CyclinD1 expression to promote pre-germinal center B-cell lymphomas in mice.
Volume: 29
Issue: 6
Pages: 1414-24
•
•
•
•
•
Publication
First Author: Sun M
Year: 2017
Journal: Cancer Res
Title: HNF1B Loss Exacerbates the Development of Chromophobe Renal Cell Carcinomas.
Volume: 77
Issue: 19
Pages: 5313-5326
•
•
•
•
•
Publication
First Author: Ihler F
Year: 2012
Journal: PLoS One
Title: Expression of a neuroendocrine gene signature in gastric tumor cells from CEA 424-SV40 large T antigen-transgenic mice depends on SV40 large T antigen.
Volume: 7
Issue: 1
Pages: e29846
•
•
•
•
•
Publication
First Author: Pajovic S
Year: 2011
Journal: Invest Ophthalmol Vis Sci
Title: The TAg-RB murine retinoblastoma cell of origin has immunohistochemical features of differentiated Muller glia with progenitor properties.
Volume: 52
Issue: 10
Pages: 7618-24
•
•
•
•
•
Publication
First Author: Hu Z
Year: 2015
Journal: J Clin Invest
Title: TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy.
Volume: 125
Issue: 1
Pages: 425-36
•
•
•
•
•
Publication
First Author: Veras MA
Year: 2019
Journal: J Cell Physiol
Title: Loss of ENT1 increases cell proliferation in the annulus fibrosus of the intervertebral disc.
Volume: 234
Issue: 8
Pages: 13705-13719
•
•
•
•
•
Publication
First Author: Lyu P
Year: 2020
Journal: Exp Cell Res
Title: Unveiling the transcriptome alteration of POMC neuron in diet-induced obesity.
Volume: 389
Issue: 1
Pages: 111848
•
•
•
•
•
Publication
First Author: Wang Y
Year: 2025
Journal: Br J Pharmacol
Title: Involvement of Piezo 1 in inhibition of shear-induced platelet activation and arterial thrombosis by ginsenoside Rb1.
Volume: 182
Issue: 9
Pages: 1957-1974
•
•
•
•
•
Publication
First Author: Oser MG
Year: 2019
Journal: Genes Dev
Title: The KDM5A/RBP2 histone demethylase represses NOTCH signaling to sustain neuroendocrine differentiation and promote small cell lung cancer tumorigenesis.
Volume: 33
Issue: 23-24
Pages: 1718-1738
•
•
•
•
•
Publication
First Author: Allaman-Pillet N
Year: 2017
Journal: Oncotarget
Title: Bigh3 silencing increases retinoblastoma tumor growth in the murine SV40-TAg-Rb model.
Volume: 8
Issue: 9
Pages: 15490-15506
•
•
•
•
•
Publication
First Author: Xu X
Year: 2019
Journal: Autophagy
Title: Gene essentiality of Tubgcp4: dosage effect and autophagy regulation in retinal photoreceptors.
Volume: 15
Issue: 10
Pages: 1834-1837
•
•
•
•
•
Publication
First Author: Smith AP
Year: 2003
Journal: Comp Med
Title: Switching of melanocyte pigmentation associated with pituitary pars intermedia tumors in Rb+/- and p27-/- female mice with yellow pelage.
Volume: 53
Issue: 1
Pages: 75-80
•
•
•
•
•
Publication
First Author: Tonks ID
Year: 2006
Journal: Pigment Cell Res
Title: Pocket protein function in melanocyte homeostasis and neoplasia.
Volume: 19
Issue: 4
Pages: 260-83
•
•
•
•
•
Publication
First Author: Ding L
Year: 2008
Journal: Nature
Title: Somatic mutations affect key pathways in lung adenocarcinoma.
Volume: 455
Issue: 7216
Pages: 1069-75
•
•
•
•
•
Publication
First Author: Ledent C
Year: 1995
Journal: Oncogene
Title: Differentiated carcinomas develop as a consequence of the thyroid specific expression of a thyroglobulin-human papillomavirus type 16 E7 transgene.
Volume: 10
Issue: 9
Pages: 1789-97
•
•
•
•
•
Publication  
First Author: Flowers S
Year: 2014
Journal: Bone
Title: p107-Dependent recruitment of SWI/SNF to the alkaline phosphatase promoter during osteoblast differentiation.
Volume: 69
Pages: 47-54
•
•
•
•
•
Publication
First Author: Li Z
Year: 2019
Journal: J Biol Chem
Title: A novel thyroid hormone receptor isoform, TR?2-46, promotes SKP2 expression and retinoblastoma cell proliferation.
Volume: 294
Issue: 8
Pages: 2961-2969
•
•
•
•
•
Publication
First Author: Cemeli T
Year: 2019
Journal: J Pathol
Title: Cytoplasmic cyclin D1 regulates glioblastoma dissemination.
Volume: 248
Issue: 4
Pages: 501-513
•
•
•
•
•
Publication
First Author: Zhao H
Year: 2017
Journal: Oncogene
Title: p27T187A knockin identifies Skp2/Cks1 pocket inhibitors for advanced prostate cancer.
Volume: 36
Issue: 1
Pages: 60-70
•
•
•
•
•
Publication  
First Author: Zhang S
Year: 2022
Journal: Front Cell Dev Biol
Title: The cell cycle inhibitor RB is diluted in G1 and contributes to controlling cell size in the mouse liver.
Volume: 10
Pages: 965595
•
•
•
•
•
Publication
First Author: Oser MG
Year: 2024
Journal: Oncogene
Title: Genetically-engineered mouse models of small cell lung cancer: the next generation.
Volume: 43
Issue: 7
Pages: 457-469
•
•
•
•
•
Publication
First Author: George J
Year: 2015
Journal: Nature
Title: Comprehensive genomic profiles of small cell lung cancer.
Volume: 524
Issue: 7563
Pages: 47-53
•
•
•
•
•
Publication
First Author: Voigt E
Year: 2021
Journal: Mol Cancer Res
Title: Sox2 Is an Oncogenic Driver of Small-Cell Lung Cancer and Promotes the Classic Neuroendocrine Subtype.
Volume: 19
Issue: 12
Pages: 2015-2025
•
•
•
•
•
Publication
First Author: Aagaard L
Year: 1999
Journal: EMBO J
Title: Functional mammalian homologues of the Drosophila PEV-modifier Su(var)3-9 encode centromere-associated proteins which complex with the heterochromatin component M31.
Volume: 18
Issue: 7
Pages: 1923-38
•
•
•
•
•
Publication
First Author: Peters AH
Year: 2001
Journal: Cell
Title: Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability.
Volume: 107
Issue: 3
Pages: 323-37
•
•
•
•
•
Publication
First Author: Peters AH
Year: 2003
Journal: Mol Cell
Title: Partitioning and plasticity of repressive histone methylation states in mammalian chromatin.
Volume: 12
Issue: 6
Pages: 1577-89
•
•
•
•
•
Publication
First Author: Rice JC
Year: 2003
Journal: Mol Cell
Title: Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains.
Volume: 12
Issue: 6
Pages: 1591-8
•
•
•
•
•
Publication
First Author: Garc?a-Cao M
Year: 2004
Journal: Nat Genet
Title: Epigenetic regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone methyltransferases.
Volume: 36
Issue: 1
Pages: 94-9
•
•
•
•
•
Publication
First Author: Vaquero A
Year: 2007
Journal: Nature
Title: SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation.
Volume: 450
Issue: 7168
Pages: 440-4
•
•
•
•
•
Publication
First Author: Alvarez-Venegas R
Year: 2002
Journal: Gene
Title: SET-domain proteins of the Su(var)3-9, E(z) and trithorax families.
Volume: 285
Issue: 1-2
Pages: 25-37
•
•
•
•
•
Publication
First Author: Firestein R
Year: 2000
Journal: Mol Cell Biol
Title: Set domain-dependent regulation of transcriptional silencing and growth control by SUV39H1, a mammalian ortholog of Drosophila Su(var)3-9.
Volume: 20
Issue: 13
Pages: 4900-9
•
•
•
•
•
Publication
First Author: Ait-Si-Ali S
Year: 2004
Journal: EMBO J
Title: A Suv39h-dependent mechanism for silencing S-phase genes in differentiating but not in cycling cells.
Volume: 23
Issue: 3
Pages: 605-15
•
•
•
•
•
Publication
First Author: Mal AK
Year: 2006
Journal: EMBO J
Title: Histone methyltransferase Suv39h1 represses MyoD-stimulated myogenic differentiation.
Volume: 25
Issue: 14
Pages: 3323-34
•
•
•
•
•
Publication
First Author: Carbone R
Year: 2006
Journal: Mol Cell Biol
Title: Recruitment of the histone methyltransferase SUV39H1 and its role in the oncogenic properties of the leukemia-associated PML-retinoic acid receptor fusion protein.
Volume: 26
Issue: 4
Pages: 1288-96
•
•
•
•
•
Publication
First Author: Bradley SP
Year: 2006
Journal: J Immunol
Title: The histone methyltransferase Suv39h1 increases class switch recombination specifically to IgA.
Volume: 177
Issue: 2
Pages: 1179-88
•
•
•
•
•
Protein Domain
Type: Family
Description: Members of this family trimethylate 'Lys-9' of histone H3 using monomethylated H3 'Lys-9' as substrate, including histone-lysine N-methyltransferase Su(var)3-9 from Drosophila melanogaster and its orthologue from human, SUV39H1. SUV39H1 also weakly methylates histone H1 (in vitro). H3 'Lys-9' trimethylation represents a specific tag for epigenetic transcriptional repression by recruiting HP1 (CBX1, CBX3 and/or CBX5) proteins to methylated histones. This enzyme mainly functions in heterochromatin regions, thereby playing a central role in the establishment of constitutive heterochromatin at pericentric and telomere regions. H3 'Lys-9' trimethylation is also required to direct DNA methylation at pericentric repeats [, , ].SUV39H1 is targeted to histone H3 via its interaction with RB1 and is involved in many processes, such as repression of MYOD1-stimulated differentiation[], regulation of the control switch for exiting the cell cycle and entering differentiation, repression by the PML-RARA fusion protein [], BMP-induced repression, repression of switch recombination to IgA []and regulation of telomere length [, ]. SUV39H1 is a component of the eNoSC (energy-dependent nucleolar silencing) complex, a complex that mediates silencing of rDNA in response to intracellular energy status and acts by recruiting histone-modifying enzymes. The eNoSC complex is able to sense the energy status of cell: upon glucose starvation, elevation of NAD+/NADP+ ratio activates SIRT1, leading to histone H3 deacetylation followed by dimethylation of H3 at 'Lys-9' (H3K9me2) by SUV39H1 and the formation of silent chromatin in the rDNA locus [].Methyltransferases (EC [ec:2.1.1.-]) constitute an important class of enzymes present in every life form. They transfer a methyl group most frequently from S-adenosyl L-methionine (SAM or AdoMet) to a nucleophilic acceptor such as oxygen leading to S-adenosyl-L-homocysteine (AdoHcy) and a methylated molecule [, , ]. All these enzymes have in common a conserved region of about 130 amino acid residues that allow them to bind SAM []. The substrates that are methylated by these enzymes cover virtually every kind of biomolecules ranging from small molecules, to lipids, proteins and nucleic acids [, , ]. Methyltransferase are therefore involved in many essential cellular processes including biosynthesis, signal transduction, protein repair, chromatin regulation and gene silencing [, , ]. More than 230 families of methyltransferases have been described so far, of which more than 220 use SAM as the methyl donor.
•
•
•
•
•
Publication
First Author: Pantoom S
Year: 2021
Journal: Autophagy
Title: RAB33B recruits the ATG16L1 complex to the phagophore via a noncanonical RAB binding protein.
Volume: 17
Issue: 9
Pages: 2290-2304
•
•
•
•
•
Publication
First Author: Chen D
Year: 2009
Journal: Nature
Title: Division and apoptosis of E2f-deficient retinal progenitors.
Volume: 462
Issue: 7275
Pages: 925-9
•
•
•
•
•
Publication  
First Author: Nguyen BT
Year: 2022
Journal: Free Radic Biol Med
Title: Ginsenoside Re attenuates memory impairments in aged Klotho deficient mice via interactive modulations of angiotensin II AT1 receptor, Nrf2 and GPx-1 gene.
Volume: 189
Pages: 2-19
•
•
•
•
•
Publication
First Author: Melcon G
Year: 2006
Journal: Hum Mol Genet
Title: Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and MyoD pathways during muscle regeneration.
Volume: 15
Issue: 4
Pages: 637-51
•
•
•
•
•
Publication
First Author: Tan KA
Year: 2005
Journal: Biol Reprod
Title: Androgen regulation of stage-dependent cyclin D2 expression in Sertoli cells suggests a role in modulating androgen action on spermatogenesis.
Volume: 72
Issue: 5
Pages: 1151-60
•
•
•
•
•
Publication
First Author: Valentine M
Year: 1989
Journal: Cytogenet Cell Genet
Title: Closely linked loci on the long arm of chromosome 13 flank a specific 2;13 translocation breakpoint in childhood rhabdomyosarcoma.
Volume: 52
Issue: 3-4
Pages: 128-32
•
•
•
•
•
Publication
First Author: Rice JM
Year: 2004
Journal: Toxicol Appl Pharmacol
Title: Causation of nervous system tumors in children: insights from traditional and genetically engineered animal models.
Volume: 199
Issue: 2
Pages: 175-91
•
•
•
•
•
Publication
First Author: Quaglia F
Year: 2021
Journal: PLoS One
Title: Differential expression of ?V?3 and ?V?6 integrins in prostate cancer progression.
Volume: 16
Issue: 1
Pages: e0244985
•
•
•
•
•
Publication
First Author: Huang M
Year: 2011
Journal: Cell Cycle
Title: Overlapping and distinct pRb pathways in the mammalian auditory and vestibular organs.
Volume: 10
Issue: 2
Pages: 337-51
•
•
•
•
•
Publication
First Author: Hu K
Year: 2025
Journal: Cancer Res Commun
Title: Development and Application of MiMouse, a Comprehensive Genomic Profiling Panel for Credentialing Mouse Tumor Models.
Volume: 5
Issue: 10
Pages: 1910-1933
•
•
•
•
•
Genotype
Symbol: Rb1/Rb1 Tg(Chx10-EGFP/cre,-ALPP)2Clc/?
Background: involves: 129/Sv * C57BL/6 * SJL
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Symbol: Rb1/Rb1 Rbl1/Rbl1 Tg(Chx10-EGFP/cre,-ALPP)2Clc/?
Background: involves: 129 * C57BL/6N * SJL
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Symbol: Hells/Hells Rb1/Rb1 Rbl1/Rbl1 Tg(Chx10-EGFP/cre,-ALPP)2Clc/?
Background: involves: 129 * C57BL/6N * SJL
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Protein
Organism: Mus musculus/domesticus
Length: 356  
Fragment?: false
•
•
•
•
•
Protein
Organism: Mus musculus/domesticus
Length: 375  
Fragment?: false
•
•
•
•
•